Interestingly, an agonist of RXRG, bexarotene, has been the focus of numerous recent studies in which it has been used to treat disease in mouse models of AD, Parkinson’s, ALS, multiple sclerosis and stroke51–54. This evidence concerns the gene RXRG and Parkinsonism.